It is because the prospective trials that compared [lumpectomy and mastectomy] didn’t enroll individuals whose tumors were larger than 5 centimeters, lead investigator Dr. Richard Bleicher, of the division of medical oncology at Fox Chase Malignancy Center in Philadelphia, described in a Fox Chase information release. Since there are no clinical trials evaluating breasts conservation therapy versus mastectomy for tumors over 5 centimeters, breast conservation is not recommended for that scenario in current suggestions still, he added. Bleicher and his colleagues analyzed data from almost 5,700 women who also had nonmetastatic breast tumors bigger than 5 centimeters who have had surgery between 1992 and 2009.This agreement may also allow Nestl – access to A*STAR's study technology and facilities. Related StoriesProper iodine diet necessary during pregnancyResearchers discover significant hyperlink between breast nutrition and cancer, explore new preventative treatmentNutrition vital for patients recovering from severe burns Mr Lim Chuan Poh, Chairman of A*STAR said, ‘A*Superstar is looking towards this excellent possibility to broaden and deepen the task that we do with the globe's leading diet and food organization to increase their R&D capabilities in Singapore. This agreement marks a substantial milestone in propelling forward A*STAR's research thrust into nutrition and meals.’ Stefan Catsicas, Nestl – Chief Technology Officer, Mind of Innovation, Technology, Analysis & Development said, ‘We are delighted to sign this research agreement with A*STAR.